Modeling Smith-Lemli-Opitz syndrome with induced pluripotent stem cells reveals a causal role for Wnt/β-catenin defects in neuronal cholesterol synthesis phenotypes

Kevin Francis, Amy N. Ton, Yao Xin, Peter E. O'Halloran, Christopher A. Wassif, Nasir Malik, Ian M. Williams, Celine V. Cluzeau, Niraj S. Trivedi, William J. Pavan, Wonhwa Cho, Heiner Westphal, Forbes D. Porter

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Smith-Lemli-Opitz syndrome (SLOS) is a malformation disorder caused by mutations in DHCR7, which impair the reduction of 7-dehydrocholesterol (7DHC) to cholesterol. SLOS results in cognitive impairment, behavioral abnormalities and nervous system defects, though neither affected cell types nor impaired signaling pathways are fully understood. Whether 7DHC accumulation or cholesterol loss is primarily responsible for disease pathogenesis is also unclear. Using induced pluripotent stem cells (iPSCs) from subjects with SLOS, we identified cellular defects that lead to precocious neuronal specification within SLOS derived neural progenitors. We also demonstrated that 7DHC accumulation, not cholesterol deficiency, is critical for SLOS-associated defects. We further identified downregulation of Wnt/β-catenin signaling as a key initiator of aberrant SLOS iPSC differentiation through the direct inhibitory effects of 7DHC on the formation of an active Wnt receptor complex. Activation of canonical Wnt signaling prevented the neural phenotypes observed in SLOS iPSCs, suggesting that Wnt signaling may be a promising therapeutic target for SLOS.

Original languageEnglish (US)
Pages (from-to)388-396
Number of pages9
JournalNature Medicine
Volume22
Issue number4
DOIs
StatePublished - Apr 1 2016
Externally publishedYes

Fingerprint

Smith-Lemli-Opitz Syndrome
Catenins
Induced Pluripotent Stem Cells
Stem cells
Cholesterol
Phenotype
Defects
Wnt Receptors
Neurology
Chemical activation
Nervous System Malformations
Specifications
7-dehydrocholesterol
Cell Differentiation
Down-Regulation
Mutation

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Modeling Smith-Lemli-Opitz syndrome with induced pluripotent stem cells reveals a causal role for Wnt/β-catenin defects in neuronal cholesterol synthesis phenotypes. / Francis, Kevin; Ton, Amy N.; Xin, Yao; O'Halloran, Peter E.; Wassif, Christopher A.; Malik, Nasir; Williams, Ian M.; Cluzeau, Celine V.; Trivedi, Niraj S.; Pavan, William J.; Cho, Wonhwa; Westphal, Heiner; Porter, Forbes D.

In: Nature Medicine, Vol. 22, No. 4, 01.04.2016, p. 388-396.

Research output: Contribution to journalArticle

Francis, K, Ton, AN, Xin, Y, O'Halloran, PE, Wassif, CA, Malik, N, Williams, IM, Cluzeau, CV, Trivedi, NS, Pavan, WJ, Cho, W, Westphal, H & Porter, FD 2016, 'Modeling Smith-Lemli-Opitz syndrome with induced pluripotent stem cells reveals a causal role for Wnt/β-catenin defects in neuronal cholesterol synthesis phenotypes', Nature Medicine, vol. 22, no. 4, pp. 388-396. https://doi.org/10.1038/nm.4067
Francis, Kevin ; Ton, Amy N. ; Xin, Yao ; O'Halloran, Peter E. ; Wassif, Christopher A. ; Malik, Nasir ; Williams, Ian M. ; Cluzeau, Celine V. ; Trivedi, Niraj S. ; Pavan, William J. ; Cho, Wonhwa ; Westphal, Heiner ; Porter, Forbes D. / Modeling Smith-Lemli-Opitz syndrome with induced pluripotent stem cells reveals a causal role for Wnt/β-catenin defects in neuronal cholesterol synthesis phenotypes. In: Nature Medicine. 2016 ; Vol. 22, No. 4. pp. 388-396.
@article{029ed188229c49d6bf364bad25723549,
title = "Modeling Smith-Lemli-Opitz syndrome with induced pluripotent stem cells reveals a causal role for Wnt/β-catenin defects in neuronal cholesterol synthesis phenotypes",
abstract = "Smith-Lemli-Opitz syndrome (SLOS) is a malformation disorder caused by mutations in DHCR7, which impair the reduction of 7-dehydrocholesterol (7DHC) to cholesterol. SLOS results in cognitive impairment, behavioral abnormalities and nervous system defects, though neither affected cell types nor impaired signaling pathways are fully understood. Whether 7DHC accumulation or cholesterol loss is primarily responsible for disease pathogenesis is also unclear. Using induced pluripotent stem cells (iPSCs) from subjects with SLOS, we identified cellular defects that lead to precocious neuronal specification within SLOS derived neural progenitors. We also demonstrated that 7DHC accumulation, not cholesterol deficiency, is critical for SLOS-associated defects. We further identified downregulation of Wnt/β-catenin signaling as a key initiator of aberrant SLOS iPSC differentiation through the direct inhibitory effects of 7DHC on the formation of an active Wnt receptor complex. Activation of canonical Wnt signaling prevented the neural phenotypes observed in SLOS iPSCs, suggesting that Wnt signaling may be a promising therapeutic target for SLOS.",
author = "Kevin Francis and Ton, {Amy N.} and Yao Xin and O'Halloran, {Peter E.} and Wassif, {Christopher A.} and Nasir Malik and Williams, {Ian M.} and Cluzeau, {Celine V.} and Trivedi, {Niraj S.} and Pavan, {William J.} and Wonhwa Cho and Heiner Westphal and Porter, {Forbes D.}",
year = "2016",
month = "4",
day = "1",
doi = "10.1038/nm.4067",
language = "English (US)",
volume = "22",
pages = "388--396",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Modeling Smith-Lemli-Opitz syndrome with induced pluripotent stem cells reveals a causal role for Wnt/β-catenin defects in neuronal cholesterol synthesis phenotypes

AU - Francis, Kevin

AU - Ton, Amy N.

AU - Xin, Yao

AU - O'Halloran, Peter E.

AU - Wassif, Christopher A.

AU - Malik, Nasir

AU - Williams, Ian M.

AU - Cluzeau, Celine V.

AU - Trivedi, Niraj S.

AU - Pavan, William J.

AU - Cho, Wonhwa

AU - Westphal, Heiner

AU - Porter, Forbes D.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Smith-Lemli-Opitz syndrome (SLOS) is a malformation disorder caused by mutations in DHCR7, which impair the reduction of 7-dehydrocholesterol (7DHC) to cholesterol. SLOS results in cognitive impairment, behavioral abnormalities and nervous system defects, though neither affected cell types nor impaired signaling pathways are fully understood. Whether 7DHC accumulation or cholesterol loss is primarily responsible for disease pathogenesis is also unclear. Using induced pluripotent stem cells (iPSCs) from subjects with SLOS, we identified cellular defects that lead to precocious neuronal specification within SLOS derived neural progenitors. We also demonstrated that 7DHC accumulation, not cholesterol deficiency, is critical for SLOS-associated defects. We further identified downregulation of Wnt/β-catenin signaling as a key initiator of aberrant SLOS iPSC differentiation through the direct inhibitory effects of 7DHC on the formation of an active Wnt receptor complex. Activation of canonical Wnt signaling prevented the neural phenotypes observed in SLOS iPSCs, suggesting that Wnt signaling may be a promising therapeutic target for SLOS.

AB - Smith-Lemli-Opitz syndrome (SLOS) is a malformation disorder caused by mutations in DHCR7, which impair the reduction of 7-dehydrocholesterol (7DHC) to cholesterol. SLOS results in cognitive impairment, behavioral abnormalities and nervous system defects, though neither affected cell types nor impaired signaling pathways are fully understood. Whether 7DHC accumulation or cholesterol loss is primarily responsible for disease pathogenesis is also unclear. Using induced pluripotent stem cells (iPSCs) from subjects with SLOS, we identified cellular defects that lead to precocious neuronal specification within SLOS derived neural progenitors. We also demonstrated that 7DHC accumulation, not cholesterol deficiency, is critical for SLOS-associated defects. We further identified downregulation of Wnt/β-catenin signaling as a key initiator of aberrant SLOS iPSC differentiation through the direct inhibitory effects of 7DHC on the formation of an active Wnt receptor complex. Activation of canonical Wnt signaling prevented the neural phenotypes observed in SLOS iPSCs, suggesting that Wnt signaling may be a promising therapeutic target for SLOS.

UR - http://www.scopus.com/inward/record.url?scp=84961389955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961389955&partnerID=8YFLogxK

U2 - 10.1038/nm.4067

DO - 10.1038/nm.4067

M3 - Article

VL - 22

SP - 388

EP - 396

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 4

ER -